Neurogene has reported encouraging efficacy results with its gene therapy for rare genetic disorder Rett syndrome, but ...
It came as AZ reported its third-quarter results, headlined by a 20% increase in revenues to $12.95 billion, which will be ...
Merck KGaA is shaping up to take on Daiichi Sankyo and Ono Pharma in the market for tenosynovial giant cell tumour (TGCT) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback